Stockreport

Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger

CEMPRA  (CEMP) 
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
PDF CHAPEL HILL, N.C. and NEW HAVEN, Conn., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing di [Read more]